"We are present throughout the entire continuum of care from prevention to treatment across different therapeutic areas, as well as a wide range of functions, from…
In Conversation
"The openness of some public health institutions such as the Bulgarian Drug Agency (BDA) and the Ministry of Health towards helping the industry to comply with…
"The private sector is highly developed and offers services of impeccable quality. Moreover, it is the reason for the medical tourism currently expanding within Tunisia and…
"Canada offers relatively transparent institutions, a demand for innovation, and leading clinical practice and expertise."
"The idea is not to cut out or remove the dermatologist from the equation because they should be part of the concept."
"Market access timelines are extending, not just in terms of obtaining market approval but also all of the hurdles that occur post-approval."
"Tunisia is a country of great resources and its industries perform well. The longstanding commitment to education needs to be leveraged upon."
Interview: Douglas Clark – Executive Director, Patented Medicines Price Review Board (PMPRB), Canada
"While our powers have changed a bit since 1987, our mandate is the same: to protect Canadian consumers from excessively-priced patented medicines, as well as to…
"The new reality of Brazil pharmaceutical industry, where productivity has gained an unprecedented importance, has clearly contributed to nurture the development and popularity of BCO Farma."
"The entire pharmaceutical supply chain has had to adapt over the past five years and it will be the case for the next few years –…
"As long as you have a good quality, experience in the field of formulation and excellent reputation there will be sufficient business."
"People often ask me, why did I not retire? I did not even take the day off!"
